Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection
Purpose Yttrium 90 (Y90) transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma (HCC) or to bridge/downstage before transplant; however, optimal patient selection is not well-described. This study aims to identify factors that increase risk of liver...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2024-08-01
|
| Serie: | Journal of Clinical Interventional Radiology ISVIR |
| Soggetti: | |
| Accesso online: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1786711 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|